Orbital

Terran Orbital Aids Successful Demonstration of Record-Breaking 1.4 Terabyte Single-Pass Optical Downlink for NASA’s Pathfinder Technology Demonstrator 3 Satellite

Retrieved on: 
Montag, Dezember 5, 2022
Aerospace, IOT (Internet of Things), Government Technology, Manufacturing, Satellite, Defense, Other Technology, Telecommunications, Other Defense, Contracts, Networks, Internet, Hardware, Data Management, Technology, Mobile, Wireless, Military, Engineering, MIT Lincoln Laboratory, Byte, MIT, Partnership, LLAP, PTD, NYSE, Government, Terran, NASA, Orbital Corporation, Orbital, Multimedia, TB, Navigation, Spacecraft, Communications satellite

NASAs Pathfinder Technology Demonstrator (PTD) mission series tests the operation of a variety of novel satellite technologies to provide significant enhancement to the performance of versatile spacecraft.

Key Points: 
  • NASAs Pathfinder Technology Demonstrator (PTD) mission series tests the operation of a variety of novel satellite technologies to provide significant enhancement to the performance of versatile spacecraft.
  • Terran Orbital designed, built, integrated, and operated the spacecraft for the first PTD satellite, PTD-1, to demonstrate a propulsion system with a water-based propellant generated via water electrolysis.
  • Terran Orbital is thrilled to have contributed to the successful 1.4 terabyte space-to-ground optical link for PTD-3, said Terran Orbital Co-Founder, Chairman, and Chief Executive Officer Marc Bell.
  • Terran Orbital is a leading manufacturer of satellite products primarily serving the aerospace and defense industries.

Orbital Infrastructure Group/GTS Subsidiary, IMMCO, Inc. Announces Office Expansion in Kochi, India

Retrieved on: 
Dienstag, November 29, 2022
Growth, OIG, Unit Deployment Program, Engineering, Annual report, Sumathi Best Television Current Reporting Award, Fiber, FTTH, Investment, Orbital, Open Telecom Platform, Telecommunication, GTS, Automation, Risk, Acquisition, Internet service provider, Video game, Access

HOUSTON, Nov. 29, 2022 /PRNewswire/ -- Orbital Infrastructure Group, Inc. (NASDAQ: OIG) ("OIG") announced today that IMMCO, Inc,  a subsidiary of OIG's Telecom Platform, GTS, has achieved record sales through 3rd Quarter 2022.  IMMCO, based in Canton, GA, with offices in India, Europe and Australia, also reported the acquisition of new office space and the hiring of 60 new employees in Kochi, India, increasing their technical engineering staff to more than 800.

Key Points: 
  • To facilitate this revenue increase and further capacity, IMMCO is undertaking its fourth office expansion in 2022, opening a new 9,500 sf facility in January of 2023.
  • The recent addition of 60 new employees takes IMMCO's staff to over 800, and the new office space will enable staffing expansion to around 1,200.
  • Orbital Infrastructure Group, Inc. is a diversified infrastructure services platform, providing engineering, design, construction, and maintenance services to customers in three operating segments: electric power, telecommunications, and renewables.
  • Orbital undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)

Retrieved on: 
Montag, November 14, 2022
Orbit, Spasm, Orbital, Observation, Clinical trial, Diplopia, TED, Teprotumumab, CAS, Significance, Eye, Huber loss, MD, Plasma, Șaeș, Investment, Autoimmune disease, Half-life, Research, Inflammation, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Gorman, Hyperglycemia, Pain, COVID-19, FDA, Therapy, Swelling, MRI, Pharmacokinetics, Immune system, Data, IND, Severe cognitive impairment, MBA, Graves' ophthalmopathy, SC, Food, Fibrosis, Uncertainty, Cedars-Sinai Medical Center, PD, Clinical, Tissue, Disclosure, Exophthalmos, Patient, Copper, Pharmaceutical industry, Medical device, EU, Safety, Viridian

Each dose is evaluated in a cohort of eight patients, with six patients randomized to receive VRDN-001 and two patients randomized to receive placebo.

Key Points: 
  • Each dose is evaluated in a cohort of eight patients, with six patients randomized to receive VRDN-001 and two patients randomized to receive placebo.
  • The inclusion and exclusion criteria and the baseline patient characteristics for this trial are in line with prior TED clinical trials.
  • The first cohort of the Phase 1/2 study evaluated a dose of 10 mg/kg, with initial positive clinical data reported on August 15, 2022, and with additional 12-week data announced today.
  • VRDN-001 was well-tolerated by all patients treated at the 20 mg/kg dose, with safety data consistent with the 10 mg/kg dose.

LunIR Joins CAPSTONE as Second Terran Orbital-Developed Lunar Satellite to Launch this Year

Retrieved on: 
Mittwoch, November 16, 2022
Defense, Technology, Satellite, Aerospace, Manufacturing, Other Defense, Artemis 1, Spacecraft, Orion, Orbital, Kongsberg Satellite Services, NASA, Artemis, Partnership, LLAP, Multimedia, Kennedy Space Center, NYSE, Human, Lockheed Martin, Lockheed, Orbital Corporation, SLS, LunIR, Centre for Analysis of Strategies and Technologies, KSAT, Communications satellite, Moon

The Moon-mapping satellite is the second Terran Orbital-developed lunar satellite to launch this year the first being CAPSTONE.

Key Points: 
  • The Moon-mapping satellite is the second Terran Orbital-developed lunar satellite to launch this year the first being CAPSTONE.
  • Terran Orbital designed, built, and integrated LunIR under contract with Lockheed Martin in support of Artemis 1 a test mission for the SLS and Orion.
  • Terran Orbital is ecstatic to launch yet another groundbreaking lunar satellite in record time, said Marc Bell, Terran Orbital Co-Founder, Chairman, and Chief Executive Officer.
  • Developing and co-operating the CAPSTONE and LunIR missions are experiences Terran Orbital will forever cherish and continually build upon.

Rocket Lab-launched CAPSTONE Spacecraft Enters Lunar Orbit

Retrieved on: 
Montag, November 14, 2022
Aerospace, Manufacturing, Satellite, Technology, Engineering, Neutron, Orbit, Spacecraft, Orbital, NASA, Artemis, Rocket Lab, Gateway, Science, Lab, Electron, NRHO, Travel, Moon, Communications satellite, Mars, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, is celebrating the successful arrival of the Electron-launched, Photon-deployed CAPSTONE spacecraft to lunar orbit.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, is celebrating the successful arrival of the Electron-launched, Photon-deployed CAPSTONE spacecraft to lunar orbit.
  • CAPSTONE was launched to low Earth orbit from Rocket Labs Launch Complex 1 on June 28 on the Electron launch vehicle.
  • From there, Rocket Labs Lunar Photon spacecraft carried out a series of obit raising maneuvers over six days, pushing CAPSTONE deeper into space before conducting a final maneuver to place CAPSTONE on a ballistic lunar transfer.
  • After delivering a successful launch and deployment for CAPSTONE almost five months ago, weve watched with bated breath as CAPSTONE drew closer to lunar orbit.

Auxon Corporation awarded SpaceWERX Orbital Prime Contract

Retrieved on: 
Montag, November 14, 2022
Transfer, Small Business Innovation Research, ADR, Technology, STTR, AFRL, Government, Partnership, Safety, ISAM, Workforce, Auxon, Industry, DAF, Air Force Research Laboratory, Department, Air force, Research, Program, Small business, United States Space Force, Policy, USSF, SBIR, Science, Orbital, Atmosphere, United States Department of the Air Force, Robotics, Renewable energy

PORTLAND, Ore., Nov. 14, 2022 /PRNewswire-PRWeb/ -- Auxon Corporation announces it has been selected by SpaceWERX for a STTR Phase I in the amount of $249,572 to investigate how its automated testing software suite might enable In-space Service Assembly and Manufacturing (ISAM) capabilities being explored by the Department of the Air Force (DAF) and United States Space Force (USSF) through the Orbital Prime program. Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation. The Air Force Research Laboratory and SpaceWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through a faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and losing bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering 'The Open Topic' SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on August 10th, 2022, Auxon will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America.

Key Points: 
  • Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation.
  • Founded in 2018, Auxon Corporation provides automated software testing solutions for robotic and cyber-physical system developers.
  • SpaceWERX Orbital Prime leverages a diverse industry partnership engagement strategy to identify nascent space technology sectors that, if "primed", could advance U.S. national security and economic prosperity.
  • The first Space Prime effort, Orbital Prime will invigorate the In-space Servicing, Assembly, and Manufacturing (ISAM) market using Active Debris Remediation (ADR) as a use case for the foundational technologies.

Orbital Infrastructure Group Schedules Third Quarter 2022 Conference Call for November 14 at 9:00 A.M. ET

Retrieved on: 
Dienstag, November 8, 2022
NASDAQ, Webcast, Engineering, SEC, Company, Risk, Private Securities Litigation Reform Act, Securities Exchange Act of 1934, EBITDA, OIG, Form 10-Q, GTS, Telecommunication, Annual report, Orbital, Security (finance)

For those planning to participate on the call, please dial +1 (800) 715-9871(domestic) or +1 (646) 307-1963 (international) and provide conference ID 1846091.

Key Points: 
  • For those planning to participate on the call, please dial +1 (800) 715-9871(domestic) or +1 (646) 307-1963 (international) and provide conference ID 1846091.
  • For those unable to attend the live call, a telephonic replay will be available until November 30, 2022.
  • Orbital Infrastructure Group, Inc. [NASDAQ: OIG] is a diversified infrastructure services platform, providing engineering, design, construction, and maintenance services to customers in three operating segments; electric power, telecommunications, and renewables.
  • Orbital undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Orbital Infrastructure Group Provides Update on Full Year 2022 Outlook

Retrieved on: 
Donnerstag, November 3, 2022
Form 10-Q, Annual report, EBITDA, Securities Exchange Act of 1934, CEO, Telecommunication, Earnings before interest, taxes, depreciation and amortization, Mission statement, Black bear, SEC, GTS, Income, Risk, Securities Act of 1933, Depreciation, Florida black bear, Workforce, Maintenance, Telecom, NASDAQ, Private Securities Litigation Reform Act, Company, Review, OIG, Carbon, Tax, Engineering, GAAP, Electric power, Electricity, Orbital, Renewable energy, Video game

While we are disappointed with the impact this project will have on our full year 2022 adjusted EBITDA, we remain on course for a record revenue year in 2022.

Key Points: 
  • While we are disappointed with the impact this project will have on our full year 2022 adjusted EBITDA, we remain on course for a record revenue year in 2022.
  • The company will provide additional business updates when it releases its Q3 2022 results expected on or before November 14, 2022.
  • Orbital Infrastructure Group, Inc. [NASDAQ: OIG] is a diversified infrastructure services platform, providing engineering, design, construction, and maintenance services to customers in three operating segments; electric power, telecommunications, and renewables.
  • Orbital undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Viridian Presents Positive Clinical Data from Ongoing VRDN-001 Phase 1/2 Trial in Active Thyroid Eye Disease (TED) Patients During Late-Breaking Presentations at the American Thyroid Association (ATA) 91st Annual Meeting

Retrieved on: 
Samstag, Oktober 22, 2022
U.S. Securities and Exchange Commission, Teprotumumab, Orbit, Plasma, Cedars-Sinai Medical Center, SEC, Therapy, Diplopia, CAS, NASDAQ, Patient, Research, Security (finance), Annual general meeting, Severe cognitive impairment, Inflammation, American Thyroid Association, Eye, Private Securities Litigation Reform Act, ATA, Orbital, Hyperglycemia, Șaeș, Company, Pain, Safety, GLOBE, Fibrosis, Forward-looking statement, Graves' ophthalmopathy, Disclosure, Half-life, Huber loss, Copper, Pharmaceutical industry, Generic drug, TED, Poster, Viridian

WALTHAM, Mass., Oct. 22, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, presented positive proof-of-concept data from the 10 mg/kg cohort in its ongoing Phase 1/2 clinical trial of VRDN-001, an anti-IGF-1R antibody, in patients with active thyroid eye disease (TED). These data, as well as new in vitro data further characterizing and differentiating the pharmacological profile of VRDN-001, were included as part of three late-breaking poster presentations at the American Thyroid Association (ATA) 91st Annual Meeting. The abstract describing new in vitro data on the distinct anti-IGF-1R profile of VRDN-001 was also selected as an oral highlighted late breaking presentation. The three posters are available on the Viridian website (click here).

Key Points: 
  • Poster #535 presents proof-of-concept data from the first cohort of patients with active TED treated in the ongoing Phase 1/2 clinical trial.
  • In patients receiving VRDN-001, proptosis response was achieved by 83% of patients, with a mean reduction of 2.4 mm from baseline.
  • Clinical Activity Score (CAS) of 0 or 1 was achieved by 83% of patients, with a mean reduction of 4.3 points from baseline.
  • Poster #568 presents full safety and pharmacodynamic data from the completed healthy volunteer portion of the ongoing Phase 1/2 trial of VRDN-001.

Space Micro Awarded Orbital Prime Contract by the United States Space Force

Retrieved on: 
Mittwoch, Oktober 19, 2022
Transfer, SAN, CA, Control system, TT&C, STTR, OSAM, SSL (company), Altius Space Machines, Voyager (Space Needle album), Sandia National Laboratories, Research, TT, Program, USSF, Multimedia, Spacecraft, Technology, Space force, Space Micro Inc, Small Business Innovation Research, Company, ISRO Telemetry, Tracking and Command Network, ADCS, Voyager, GEO, Telemetry, View, Orbital, Communications satellite, Risk management, Barnacle, Command

SAN DIEGO, Oct. 19, 2022  /PRNewswire/ -- Space Micro Inc, powered by Voyager Space, has been awarded an Orbital Prime contract by the U.S. Space Force (USSF) as part of the first phase of the Small Business Technology Transfer (STTR) program. Space Micro proposed the development of Control Moment Gyro Barnacle (Barnacle), a robotic spacecraft that would replace or restore Attitude Determination and Control Systems (ADCS) capabilities and to expand on-orbit servicing, assembly, and manufacturing (OSAM).

Key Points: 
  • The BarnaclewillhelpaddressthisneedbyaugmentingspacecraftwithadditionalADCStechnology and coordinating control of the target spacecraft, allowing USSF to resurrect key space assets that were previously lost.
  • "We are excited to have won this Space Force contract as part of the first-ever Orbital Prime program," said Space Micro Executive Chair, David J. Strobel.
  • It allows Space Micro to validate the work our team has been doing to bring the technology to life.
  • Voyager Space is a space technology company dedicated to building a better future for humanity in space and on Earth.